Baxter International Inc. (BAX) Expected to Announce Earnings of $0.59 Per Share
Equities analysts expect Baxter International Inc. (NYSE:BAX) to announce earnings of $0.59 per share for the current quarter, Zacks reports. Six analysts have provided estimates for Baxter International’s earnings. The highest EPS estimate is $0.60 and the lowest is $0.57. Baxter International posted earnings of $0.57 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 3.5%. The business is scheduled to announce its next quarterly earnings report on Wednesday, February 7th.
On average, analysts expect that Baxter International will report full-year earnings of $2.42 per share for the current fiscal year, with EPS estimates ranging from $2.38 to $2.45. For the next fiscal year, analysts forecast that the business will report earnings of $2.70 per share, with EPS estimates ranging from $2.62 to $2.85. Zacks’ earnings per share calculations are a mean average based on a survey of research analysts that cover Baxter International.
Baxter International (NYSE:BAX) last announced its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.59 by $0.05. The company had revenue of $2.71 billion for the quarter, compared to analyst estimates of $2.66 billion. Baxter International had a return on equity of 15.00% and a net margin of 9.88%. Baxter International’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.56 earnings per share.
In other news, Director Thomas T. Stallkamp sold 8,920 shares of Baxter International stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $62.28, for a total value of $555,537.60. Following the completion of the sale, the director now directly owns 16,263 shares in the company, valued at $1,012,859.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Third Point Llc sold 5,000,000 shares of Baxter International stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $64.23, for a total transaction of $321,150,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,035,050 shares of company stock valued at $323,308,587. 0.05% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Colony Group LLC bought a new stake in shares of Baxter International during the third quarter worth $6,966,000. Neuberger Berman Group LLC grew its stake in shares of Baxter International by 5.2% in the third quarter. Neuberger Berman Group LLC now owns 55,935 shares of the medical instruments supplier’s stock worth $3,510,000 after purchasing an additional 2,755 shares during the last quarter. Piedmont Investment Advisors LLC grew its stake in shares of Baxter International by 1.4% in the third quarter. Piedmont Investment Advisors LLC now owns 187,015 shares of the medical instruments supplier’s stock worth $11,735,000 after purchasing an additional 2,524 shares during the last quarter. California Public Employees Retirement System grew its stake in shares of Baxter International by 3.4% in the third quarter. California Public Employees Retirement System now owns 1,450,242 shares of the medical instruments supplier’s stock worth $91,003,000 after purchasing an additional 47,076 shares during the last quarter. Finally, Kalos Management Inc. bought a new stake in shares of Baxter International in the third quarter worth $566,000. 82.85% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Baxter International (NYSE BAX) traded up $0.05 during mid-day trading on Wednesday, hitting $64.46. The stock had a trading volume of 2,304,800 shares, compared to its average volume of 2,675,944. Baxter International has a twelve month low of $43.13 and a twelve month high of $65.70. The company has a quick ratio of 2.22, a current ratio of 2.80 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $35,092.62, a P/E ratio of 26.62, a price-to-earnings-growth ratio of 2.16 and a beta of 0.68.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 2nd. Shareholders of record on Friday, December 1st will be given a dividend of $0.16 per share. The ex-dividend date is Thursday, November 30th. This represents a $0.64 annualized dividend and a yield of 0.99%. Baxter International’s dividend payout ratio (DPR) is presently 34.41%.
Baxter International Company Profile
Baxter International Inc, through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Baxter International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.